Search results
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 4 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Firstcry, Snapdeal-owned Unicommerce, Interarch Building Products, Gala Precision get Sebi nod to...
CNBC Awaaz· 4 days agoBrainbees Solutions, the parent company of online e-commerce platform FirstCry, has received...
Emcure Pharma On The Way To D-Street Debut; IPO On July 3
Free Press Journal· 5 days agoThe Initial Public Offer of 'Emcure Pharmaceutical's will begin accepting subscriptions on July 3. A...
Hina Khan details cancer battle, gives a shout-out to those fighting the disease: ‘Scarred but not...
Indian Express· 5 days agoThe news of Hina Khan’s battle with Stage 3 breast cancer sent shockwaves among her fans and...
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 5 days agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Kareena Kapoor Khan Clocks 24 Years In Bollywood, Promises 'The Best Is Yet To Come'
Free Press Journal· 6 days agoThe romantic drama film directed by JP Dutta also starred Jackie Shroff, Sunil Shetty and Anupam...
IPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week
CNBC Awaaz· 6 days agoThe primary market is gearing up for another stellar week as three companies are set to launch their...
Emcure Pharma IPO: Here’s what GMP signals ahead of opening for subscription | Stock Market News
Livemint· 6 days agoThe Pune-based Emcure Pharma is all set to launch its initial public offerings (IPO) next week. The...
'You Are A Fighter': Cancer Survivor Mahima Chaudhry Reacts To Hina Khan’s Diagnosis
Free Press Journal· 7 days agoMahima reacted to Hina Khan's post, sending affection and prayers to the actress, who is suffering...
Emcure Pharma IPO: GMP rises sharply ahead of issue opening for subscription on July 3 - CNBC TV18
CNBC TV18· 7 days agoShares of Emcure Pharmaceuticals are trading at a premium of ₹270 in the unlisted market on Saturday...